← Leaderboards
Craig Stephen Atwood
Weill Medical Coll Of Cornell Univ
$3,450,899
Attributed
$8,371,542
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2013–24$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,371,542 · 4
VA$0 · 2
By mechanism
R01$7,857,385 · 2
R41$364,157 · 1
R56$150,000 · 1
I21$0 · 2
Top collaborators
- Tracy A. Butler5 shared
- James E Galvin5 shared
- Robert F Krueger1 shared
- Carol D. Ryff1 shared
- Teresa E Seeman1 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Tracy A. Butler$6,223,307
- James E Galvin$66,836,874
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCognitionCognitiveGonadal Steroid HormonesLuteinizing HormonePlasmaAdultCostS DiseaseHippocampus (Brain)Leuprolide AcetateResponseBiological MarkersSerumS Disease RiskWomanMotivationLegal PatentImpaired CognitionDoseInflammatoryC-Reactive ProteinAgingAtrophic
Grant awards (14)
The LUCINDA Trial$1,365,893
R01 · FY2024 · AG
The LUCINDA Trial$1,366,388
R01 · FY2022 · AG
The LUCINDA Trial$1,413,113
R01 · FY2021 · AG
The LUCINDA Trial$1,463,084
R01 · FY2019 · AG
The LUCINDA Trial$1,603,736
R01 · FY2018 · AG
A Novel Biologic for the Treatment of Hypogonadism$364,157
R41 · FY2016 · AG · contact PI
hCG Therapy in the Treatment of Traumatic Brain Injury$0
I21 · FY2015 · VA · contact PI
hCG Therapy in the Treatment of Traumatic Brain Injury$0
I21 · FY2015 · VA · contact PI
Epistasis in Steroidogenic Genes in the Prediction of Alzheimer's Disease$0
I21 · FY2014 · VA · contact PI
What Genes Experience:Environmental Moderators of Genetic Risk in MIDUS$150,000
R56 · FY2013 · AG
Epistasis in Steroidogenic Genes in the Prediction of Alzheimer's Disease$0
I21 · FY2013 · VA · contact PI
Antiapoptotic Activity of Alzheimer Abeta$186,171
R01 · FY2003 · AG
Antiapoptotic Activity of Alzheimer Abeta$229,500
R01 · FY2002 · AG
Antiapoptotic Activity of Alzheimer Abeta$229,500
R01 · FY2001 · AG